Stockscreener 앱 받기
17.16
2.22%
-0.39
시간 외 거래:
17.16
전일 마감가:
$17.55
열려 있는:
$17.55
하루 거래량:
774.78K
Relative Volume:
1.41
시가총액:
$2.26B
수익:
-
순이익/손실:
$-151.09M
주가수익비율:
-9.4807
EPS:
-1.81
순현금흐름:
$-160.51M
1주 성능:
+3.56%
1개월 성능:
+2.51%
6개월 성능:
+93.68%
1년 성능:
+130.96%
1일 변동 폭
$16.94
$17.94
1주일 범위
$15.88
$18.12
52주 변동 폭
$6.65
$18.97
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Company Profile
명칭
Centessa Pharmaceuticals Plc Adr
전화
44 7391 789784
주소
3RD FLOOR, ALTRINCHAM, CHESHIRE
CNTA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CNTA
Centessa Pharmaceuticals Plc Adr
|
17.16 | 2.26B | 0 | -151.09M | -160.51M | -1.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-09-20 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-19 | 개시 | B. Riley Securities | Buy |
| 2024-07-18 | 개시 | Oppenheimer | Outperform |
| 2023-11-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-10-26 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2023-06-21 | 개시 | Evercore ISI | Outperform |
| 2023-06-12 | 개시 | Guggenheim | Buy |
| 2023-03-17 | 개시 | SVB Securities | Outperform |
| 2022-08-12 | 다운그레이드 | Morgan Stanley | Overweight → Underweight |
| 2022-06-17 | 개시 | BMO Capital Markets | Outperform |
| 2022-06-03 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-02-11 | 개시 | Goldman | Neutral |
모두보기
Centessa Pharmaceuticals Plc Adr 주식(CNTA)의 최신 뉴스
Centessa Pharmaceuticals CEO sells $959,057 in shares - Investing.com
Centessa Pharmaceuticals general counsel sells shares for $1.27 million - Investing.com
Stock Market Recap: Tencent Music Entertainment Group ADR (TME) Concludes at 11.30, a -5.68 Surge/Decline - The Dwinnex
Banzai International Inc (NASDAQ: BNZI): Getting A Free Pass? - Stocks Register
Metrics That Matter About Credo Technology Group Holding Ltd (NASDAQ: CRDO) - Stocks Register
Centessa Pharmaceuticals stock hits 52-week high at $18.77 By Investing.com - Investing.com UK
Centessa Pharmaceuticals CEO Saha Saurabh sells $5,450 in shares - Investing.com India
Centessa Pharmaceuticals' chief business officer sells $176,601 in shares - Investing.com
Centessa Pharmaceuticals CEO Saurabh sells shares worth $1.02 million - Investing.com India
Centessa Pharmaceuticals CEO Saurabh sells shares worth $1.02 million By Investing.com - Investing.com South Africa
Deutsche Bank initates Fidelity National Financial Inc (FNF) stock to a Hold - Knox Daily
Centessa Pharmaceuticals CEO sells shares worth $585,418 - Investing.com India
Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business Update - GlobeNewswire Inc.
Endava PLC Sponsored ADR (DAVA) Beats Q1 Earnings Estimates - Yahoo Finance
XPeng Inc. Sponsored ADR (XPEV) Stock Moves -1.06%: What You Should Know - Yahoo Finance
Centessa Pharmaceuticals' chief business officer sells shares for $180,628 - Investing.com
Zai Lab Limited (ZLAB) Moves 14.7% Higher: Will This Strength Last? - Yahoo Finance
Centessa Pharmaceuticals plcADR (CNTA) Price Target Increased by 14.58% to 11.22 - MSN
Centessa Pharmaceuticals CEO sells shares worth $863,727 - Investing.com
Are Finance Stocks Lagging Balfour Beatty PLC Sponsored ADR (BLFBY) This Year? - Yahoo Finance
Centessa Pharmaceuticals plc ADR (CNTA) expanding its growth trajectory ahead - SETE News
GSK Plc ADR [GSK] Insider Activity: An Update for Investors - Knox Daily
Centessa Pharmaceuticals plc ADR (CNTA) Stock: Uncovering 52-Week Market Trends - The InvestChronicle
Analysts review Bilibili Inc ADR’s rating - Knox Daily
Centessa Pharmaceuticals plc ADR (CNTA) shows promising results - US Post News
Ratios Uncovered: Breaking Down Centessa Pharmaceuticals plc ADR (CNTA)’s Trailing Twelve Months Metrics - The Dwinnex
Centessa Pharmaceuticals executive sells over $260k in company stock - Investing.com India
Centessa Pharmaceuticals executive sells over $260k in company stock By Investing.com - Investing.com South Africa
Centessa Pharmaceuticals plc ADR [CNTA] Shares Rise 2.15 % on Thursday - Knox Daily
Centessa Pharmaceuticals plc ADR (CNTA) is looking forward to a strong quarter - SETE News
Centessa's ORX142 shows promise for treating daytime sleepiness - Investing.com India
Sea Limited Sponsored ADR (SE) Outperforms Broader Market: What You Need to Know - Yahoo Finance
Monitoring Accenture plc (ACN) after recent insider movements - Knox Daily
ALLE stock rated an Underweight by Barclays - Knox Daily
Understanding the Risks of Investing in BranchOut Food Inc (BOF) - Knox Daily
EON Resources Inc. [EONR] Investment Guide: What You Need to Know - Knox Daily
Analysts review Reneo Pharmaceuticals Inc’s rating - Knox Daily
Analyzing Pineapple Energy Inc (PEGY) After Recent Trading Activity - Knox Daily
Investing in nVent Electric plc (NVT): What You Must Know - Knox Daily
Peraso Inc’s latest rating changes from various analysts - Knox Daily
Fiserv, Inc. [FI] Insider Bisignano Frank sells 145,000 Shares – Latest Insider Activity - Knox Daily
The Attractiveness of Investing In GE Aerospace (GE) is Growing - Knox Daily
President and CEO, MADER MARK PATRICK sold 20,000 shares of Smartsheet Inc [SMAR] - Knox Daily
Henry Schein Inc. [HSIC] Insider McGlynn Lorelei sells 21,035 Shares – McGlynn Lorelei Activity - Knox Daily
A Guide To The Risks Of Investing In Autodesk Inc. (ADSK) - Knox Daily
Is it a good time to sell Xcel Energy, Inc. [XEL] shares after an insider sold 2,041 shares? - Knox Daily
Chief Executive Officer, Scots-Knight Denise sold 60,046 shares of Mereo Biopharma Group Plc ADR [MREO] - Knox Daily
Verona Pharma Plc ADR [VRNA] President and CEO makes an insider sale of 600,000 shares worth $2.25 million. - Knox Daily
Recent Insider Activity Could Benefit Tractor Supply Co. (TSCO) - Knox Daily
Examining the Potential Price Growth of Biomarin Pharmaceutical Inc. (BMRN) - Knox Daily
The Potential Rise in the Price of Ventas Inc (VTR) following insiders activity - Knox Daily
Centessa Pharmaceuticals Plc Adr (CNTA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.88%
2.65%
자본화:
|
볼륨(24시간):